EUVIMEDEUVIMED entdecken
FallberichtOpen Access

A case of prazosin in treatment of rapid eye movement sleep behavior disorder

Yeilim Cho, Jeffrey J Iliff, Miranda M Lim, Murray Raskind, Elaine Peskind

Journal of Clinical Sleep Medicine · 2024

DOI: 10.5664/jcsm.10888 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical Sleep Medicine, 2024. Verfasst von Yeilim Cho und 4 weiteren Autor:innen. Beteiligte Einrichtung: VISN 20 Mental Illness Research, Education and Clinical Center, Seattle, Washington. Hauptthemen laut MEDLINE: Melatonin, REM Sleep Behavior Disorder, Stress Disorders, Post-Traumatic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, CSRD VA, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid eye movement (REM) sleep behavior disorder (RBD) is characterized by dream-enactment behaviors that emerge during a loss of REM sleep atonia. Untreated RBD carries risks for physical injury from falls or other traumatic events during dream enactment as well as risk of injury to the bed partner. Currently, melatonin and clonazepam are the mainstay pharmacological therapies for RBD. However, therapeutic response to these medications is variable. While older adults are most vulnerable to RBD, they are also particularly vulnerable to the adverse effects of benzodiazepines, including increased risk of falls, cognitive impairment, and increased risk of Alzheimer disease. Prazosin is a centrally active alpha-1 adrenergic receptor antagonist often prescribed for trauma nightmares characterized by REM sleep without atonia in patients with posttraumatic stress disorder. We report a case of successful RBD management with prazosin in a patient in whom high-dose melatonin was ineffective. Although there was no observable reduction in dream-enactment behaviors with high-dose melatonin, the possibility of a synergistic effect of prazosin combined with melatonin cannot be ruled out. This case report supports further evaluation of prazosin as a potential therapeutic for RBD. CITATION: Cho Y, Iliff JJ, Lim MM, Raskind M, Peskind E. A case of prazosin in treatment of rapid eye movement sleep behavior disorder. J Clin Sleep Med. 2024;20(2):319-321.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninREM Sleep Behavior DisorderStress Disorders, Post-TraumaticHumansAgedPrazosinClonazepam

Stichwörter der Autor:innen

REM sleep behavior disorderdreamenactmentprazosin

Substanzen

MelatoninPrazosinClonazepam

Autor:innen und Institutionen

  • VISN 20 Mental Illness Research, Education and Clinical Center, Seattle, Washington.
  • Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington.
  • Department of Neurology, University of Washington School of Medicine, Seattle, Washington.
  • VA Portland Health Care System, Research Service, Portland, Oregon.
  • Oregon Health and Science University, Neurology, Portland, Oregon.
  • Oregon Health and Science University, Behavioral Neuroscience, Portland, Oregon.

Förderung

  • BLRD VA
  • CSRD VA
  • NIA NIH HHS

Zitieren

APA

Cho, Y., Iliff, J. J., Lim, M. M., Raskind, M., & Peskind, E. (2024). A case of prazosin in treatment of rapid eye movement sleep behavior disorder. Journal of Clinical Sleep Medicine. https://doi.org/10.5664/jcsm.10888

Vancouver

Cho Y, Iliff JJ, Lim MM, Raskind M, Peskind E. A case of prazosin in treatment of rapid eye movement sleep behavior disorder. Journal of Clinical Sleep Medicine. 2024. doi:10.5664/jcsm.10888

BibTeX
@article{Cho2024,
  author = {Cho, Yeilim and Iliff, Jeffrey J and Lim, Miranda M and Raskind, Murray and Peskind, Elaine},
  title = {A case of prazosin in treatment of rapid eye movement sleep behavior disorder},
  journal = {Journal of Clinical Sleep Medicine},
  year = {2024},
  doi = {10.5664/jcsm.10888}
}
Kostenlos starten →